Evidence map›Paper›PMID 17968874›Full record

ArticleArthritis and rheumatism2007

Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients.

James C Oates, Libby W Farrelly, Ann F Hofbauer, Wei Wang, Gary S Gilkeson

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Apoptosis - an Ubiquitous T cell Immunomodulator.Journal of clinical & cellular immunology · 2011
    Article
  6. Mechanisms of tissue injury in lupus nephritis.Arthritis research & therapy · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

James C OatesMedical University of South Carolina, Department of Medicine, Division of Rheumatology, Charleston, SC 29425, USA. oatesjc@musc.edu
Libby W Farrelly
Ann F Hofbauer
Wei Wang
Gary S Gilkeson
Medical University of South Carolina · US

Funding

ZINC AND COPPER METABOLISM IN COLLAGEN DISORDERSM01RR001070 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI REVES, JOSEPH G · 1985 to 2009
$16.3M
Role of reactive intermediates in lupus nephritisR01AR045476 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S, OATES, JAMES C · 1999 to 2012
$3.5M
ROLE OF COMPLEMENT FACTOR B IN THE PATHOGENESIS OF SLER01AI047469 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S. · 2000 to 2004
$1.2M
Role of nitric oxide and eicosanoids in lupus nepthritisK08AR002193 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OATES, JAMES C · 2001 to 2005
$635k
NCRR NIH HHS M01 RR001070NCRR NIH HHS M01-RR-01070NIAID NIH HHS AI-047469NIAID NIH HHS R01 AI047469NIAMS NIH HHS AR-045476NIAMS NIH HHS AR-04745NIAMS NIH HHS K08 AR002193NIAMS NIH HHS K08-AR-002193NIAMS NIH HHS R01 AR045476
6 · The paper itself

Abstract

objectiveBoth increased production of reactive oxygen and nitrogen intermediates (RONI) and reduced levels of complement may play a role in the increased apoptosis and reduced clearance of apoptotic cells in systemic lupus erythematosus (SLE). The objective of this study was to evaluate both processes in a parallel, prospective, longitudinal manner.

methodsSixty-seven SLE patients were evaluated during multiple visits, and 31 healthy control subjects were evaluated once or twice. Clinical and laboratory features of SLE disease activity were determined, and blood was collected for measurement of serum nitrate plus nitrite (NOx) levels and for isolation of peripheral blood mononuclear cells (PBMCs). PBMCs were cultured with a nitric oxide (NO) donor and SLE or control plasma, with or without heat inactivation, cobra venom factor (CVF), or lipopolysaccharide plus interferon-gamma treatment. Cells were analyzed for apoptotic index (AI), cellular subsets, and RONI production.

resultsThe PBMC AI was associated with SLE and was inversely associated with complement levels over time. Changes in the AI with addition of a NO donor was longitudinally associated with serum NOx levels, and stimulation of SLE PBMCs led to parallel increases in RONI production and apoptosis. Addition of SLE plasma resulted in a greater PBMC AI, an effect that was increased with heat inactivation and was corrected with CVF treatment.

conclusionThese data suggest that the greater AI observed in SLE PBMCs relates to increased PBMC RONI production and reduced complement levels. The longitudinal nature of these parallel associations within individuals suggests that these processes are dynamic and additive.

Indexed as

AdultAntiviral AgentsApoptosisCells, CulturedComplement Inactivating AgentsComplement System ProteinsElapid VenomsFemaleHumansInterferon-gammaLeukocytes, MononuclearLipopolysaccharidesLongitudinal StudiesLupus Erythematosus, SystemicMaleNitric Oxide DonorsAntiviral Agentscobra venom factorComplement Inactivating AgentsComplement System ProteinsElapid VenomsInterferon-gammaLipopolysaccharidesNitric Oxide DonorsReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID17968874
PMCPMC2733836
OpenAlexW2074090674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.